SPARC announces retirement of Dr Chitturi Trinadha Rao - Senior Vice President, Drug Discovery Ruchika Sharma3 Nov 2023 1:30 PM ISTMumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced that Dr Chitturi Trinadha Rao – Senior Vice President, Drug Discovery,...
SPARC licenses PDP-716, SDN-037 drug rights to Visiox Pharma Ruchika Sharma8 Dec 2021 1:20 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) today announced that the company has entered into an agreement with Visiox Pharma LLC...
SPARC, Biomodifying ink antibody licensing agreement Ruchika Sharma4 Dec 2021 1:11 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) has recently announced that the company has entered into an agreement with Biomodifying LLC...
Appointment of Anilkumar Raghavan as CEO gets SPARC shareholders nod Ruchika Sharma1 Oct 2021 4:29 PM ISTNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Thursday said its shareholders have approved the appointment of Anilkumar Raghavan as chief...
Sun Pharma Advanced Research Company to raise up to Rs 1800 crore Medical Dialogues Team2 Sept 2021 9:00 AM ISTNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Wednesday said it will seek shareholders' approval to raise up to Rs 1,800 crore through...
SPARC reports positive results from Phase 3 trial of ocular hypertension treatment Ruchika Sharma16 May 2021 10:00 AM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) has recently reported positive top-line results from its Phase 3 trial (CLR_16_33) for...
SPARC issues warrants worth Rs 1,200 crore to promoter Dilip Shanghvi, others Ruchika Sharma14 May 2021 12:31 PM ISTNew Delhi: Sun Pharma Advanced Research Company (SPARC) plans to raise up to Rs 1,200 crore by way of issuing warrants to the company''s promoter...
Sun Pharma Advanced Research Company application for cancer drug Taclantis denied by USFDA Ruchika Sharma24 Feb 2021 1:18 PM ISTNew Delhi: Sun Pharma Advanced Research Company Ltd on Tuesday said the USFDA has ruled against its appeal related to Taclantis, its under...
SPARC investigational drug shows promise in phase 3 trial for treating inflammation, pain related to ocular surgery Ruchika Sharma15 Oct 2020 12:30 PM ISTThe objective of the trial was to assess the efficacy and safety of SDN-037 in clearing the inflammation and pain, the company added.
SPARC, Tripoint ink licensing pact for Elepsia XR tablets in US Ruchika Sharma22 Sept 2020 1:00 PM IST"Elepsia XR can bring down the daily pill burden significantly and will be an alternative treatment option for patients suffering with epilepsy," said...
SPARC, Sun Pharma enter into license agreement for SCD-044, a potential treatment for atopic dermatitis, psoriasis, more Ruchika Sharma29 May 2020 4:25 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. and Sun Pharmaceutical Industries Ltd. have announced a worldwide licensing agreement on the...
Expect delay in start of royalty from 2 new drugs: SPARC savita thakur thakur1 Jan 2016 12:16 PM ISTNEW DELHI: Sun Pharma Advanced Research Company (SPARC) expects further delay in start of royalty income from its two new drug applications, including...
